Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-12-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2020.609274/full |
id |
doaj-94ca53e8c7d44aeb90f569b3cd2745d3 |
---|---|
record_format |
Article |
spelling |
doaj-94ca53e8c7d44aeb90f569b3cd2745d32020-12-09T06:45:56ZengFrontiers Media S.A.Frontiers in Pharmacology1663-98122020-12-011110.3389/fphar.2020.609274609274Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases?Claudio Viegas0Carlos A. Manssour Fraga1Maria Emilia Sousa2Andrea Tarozzi3Institute of Biomedical Sciences, Federal University of Rio de Janeiro, Rio de Janeiro, BrazilFaculty of Pharmacy, University of Porto, Porto, PortugalDepartment for Life Quality Studies, University of Bologna, Bologna, ItalyLaboratory of Research in Medicinal Chemistry (PeQuiM), Federal University of Alfenas, Alfenas, Brazilhttps://www.frontiersin.org/articles/10.3389/fphar.2020.609274/fulloxidative stressneurodegenerative diseasesAlzheirmer's diseaseParkinsion’s diseaseHuntington (disease)amyotrofic lateral sclerosis |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Claudio Viegas Carlos A. Manssour Fraga Maria Emilia Sousa Andrea Tarozzi |
spellingShingle |
Claudio Viegas Carlos A. Manssour Fraga Maria Emilia Sousa Andrea Tarozzi Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? Frontiers in Pharmacology oxidative stress neurodegenerative diseases Alzheirmer's disease Parkinsion’s disease Huntington (disease) amyotrofic lateral sclerosis |
author_facet |
Claudio Viegas Carlos A. Manssour Fraga Maria Emilia Sousa Andrea Tarozzi |
author_sort |
Claudio Viegas |
title |
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_short |
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_full |
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_fullStr |
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_full_unstemmed |
Editorial: Oxidative Stress: How Has It Been Considered in the Design of New Drug Candidates for Neurodegenerative Diseases? |
title_sort |
editorial: oxidative stress: how has it been considered in the design of new drug candidates for neurodegenerative diseases? |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Pharmacology |
issn |
1663-9812 |
publishDate |
2020-12-01 |
topic |
oxidative stress neurodegenerative diseases Alzheirmer's disease Parkinsion’s disease Huntington (disease) amyotrofic lateral sclerosis |
url |
https://www.frontiersin.org/articles/10.3389/fphar.2020.609274/full |
work_keys_str_mv |
AT claudioviegas editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT carlosamanssourfraga editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT mariaemiliasousa editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases AT andreatarozzi editorialoxidativestresshowhasitbeenconsideredinthedesignofnewdrugcandidatesforneurodegenerativediseases |
_version_ |
1724388318241619968 |